Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea
· Delayed Price · Currency is KRW 9,600.00
-1,380.00 (-12.57%)
At close: Dec 5, 2025
Pharos iBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Operating Revenue | - | - | - | 300 | 57 | 187.68 | Upgrade
|
| Other Revenue | - | - | - | - | -0 | - | Upgrade
|
| Revenue | - | - | - | 300 | 57 | 187.68 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 426.32% | -69.63% | -55.43% | Upgrade
|
| Cost of Revenue | 14.08 | 25.93 | 11.02 | 192.49 | 52.09 | 213.76 | Upgrade
|
| Gross Profit | -14.08 | -25.93 | -11.02 | 107.52 | 4.91 | -26.08 | Upgrade
|
| Selling, General & Admin | 2,881 | 3,276 | 3,226 | 2,988 | 2,459 | 1,481 | Upgrade
|
| Research & Development | 7,710 | 8,458 | 6,138 | 7,085 | 5,544 | 4,340 | Upgrade
|
| Amortization of Goodwill & Intangibles | 73.25 | 71.31 | 69.18 | 67.33 | 111.15 | 52.11 | Upgrade
|
| Other Operating Expenses | 48.77 | 38.31 | 56.29 | 75.93 | 57.34 | 44.09 | Upgrade
|
| Operating Expenses | 11,473 | 12,575 | 10,106 | 10,727 | 8,411 | 6,021 | Upgrade
|
| Operating Income | -11,487 | -12,601 | -10,117 | -10,619 | -8,406 | -6,047 | Upgrade
|
| Interest Expense | -8.59 | -6.01 | -11.24 | -3,222 | -6,513 | -4,278 | Upgrade
|
| Interest & Investment Income | 461.22 | 809.98 | 690.24 | 320.48 | 116.43 | 105.06 | Upgrade
|
| Currency Exchange Gain (Loss) | 339.3 | 717.62 | 28.37 | 346.05 | 205.32 | -180.24 | Upgrade
|
| Other Non Operating Income (Expenses) | 872.66 | 556.6 | 592.65 | -3,911 | -16,877 | -2,971 | Upgrade
|
| EBT Excluding Unusual Items | -9,823 | -10,523 | -8,817 | -17,086 | -31,474 | -13,371 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -27.15 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -37.27 | -41.7 | 24.43 | 3.2 | - | Upgrade
|
| Pretax Income | -9,823 | -10,560 | -8,858 | -17,062 | -31,471 | -13,398 | Upgrade
|
| Net Income | -9,823 | -10,560 | -8,858 | -17,062 | -31,471 | -13,398 | Upgrade
|
| Net Income to Common | -9,823 | -10,560 | -8,858 | -17,062 | -31,471 | -13,398 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 12 | 9 | 6 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 12 | 9 | 6 | 6 | Upgrade
|
| Shares Change (YoY) | 0.11% | 6.79% | 36.26% | 53.03% | 2.65% | 1.86% | Upgrade
|
| EPS (Basic) | -759.21 | -817.18 | -732.03 | -1921.10 | -5422.59 | -2369.66 | Upgrade
|
| EPS (Diluted) | -759.21 | -817.18 | -732.03 | -1921.10 | -5422.59 | -2369.66 | Upgrade
|
| Free Cash Flow | -8,611 | -10,004 | -8,253 | -8,512 | -8,489 | -5,551 | Upgrade
|
| Free Cash Flow Per Share | -665.54 | -774.15 | -681.98 | -958.46 | -1462.70 | -981.82 | Upgrade
|
| Gross Margin | - | - | - | 35.84% | 8.61% | -13.90% | Upgrade
|
| Operating Margin | - | - | - | -3539.83% | -14747.27% | -3221.86% | Upgrade
|
| Profit Margin | - | - | - | -5687.23% | -55211.96% | -7138.82% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -2837.42% | -14892.94% | -2957.82% | Upgrade
|
| EBITDA | -10,654 | -11,798 | -9,432 | -10,041 | -8,056 | -5,891 | Upgrade
|
| D&A For EBITDA | 832.97 | 802.91 | 684.91 | 578.1 | 350.09 | 155.37 | Upgrade
|
| EBIT | -11,487 | -12,601 | -10,117 | -10,619 | -8,406 | -6,047 | Upgrade
|
| Advertising Expenses | - | 47.12 | - | - | 0.2 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.